QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2021 Financial Report
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, has reported its third-quarter 2021 financial numbers. The company noted that the report, which is for the period ended Sept. 30, 2021, shows operational and technical achievements that set the stage for major growth and profitability expected in 2022. Highlights of the report include total revenue for Q3 2021 reaching $518,000, instrumental sales totaled $274,200, with consumable sales for the quarter topping $46,000. Year-to-date numbers shows…